Cargando…

Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal

OBJECTIVE: The goal of this investigation was to evaluate circulating and skeletal muscle inflammatory biomarkers between maintenance hemodialysis (MHD) and demographic-matched control subjects (CON) before and after ingestion of a protein-rich meal. DESIGN AND METHODS: CON (n = 8; 50 ± 2 years; 31...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkins, Ryan K., van Vliet, Stephan, Miranda, Edwin R., Fuller, Kelly N. Z., Beisswenger, Paul J., Wilund, Kenneth R., Paluska, Scott A., Burd, Nicholas A., Haus, Jacob M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580815/
https://www.ncbi.nlm.nih.gov/pubmed/34923111
http://dx.doi.org/10.1053/j.jrn.2021.11.006
_version_ 1785122016751255552
author Perkins, Ryan K.
van Vliet, Stephan
Miranda, Edwin R.
Fuller, Kelly N. Z.
Beisswenger, Paul J.
Wilund, Kenneth R.
Paluska, Scott A.
Burd, Nicholas A.
Haus, Jacob M.
author_facet Perkins, Ryan K.
van Vliet, Stephan
Miranda, Edwin R.
Fuller, Kelly N. Z.
Beisswenger, Paul J.
Wilund, Kenneth R.
Paluska, Scott A.
Burd, Nicholas A.
Haus, Jacob M.
author_sort Perkins, Ryan K.
collection PubMed
description OBJECTIVE: The goal of this investigation was to evaluate circulating and skeletal muscle inflammatory biomarkers between maintenance hemodialysis (MHD) and demographic-matched control subjects (CON) before and after ingestion of a protein-rich meal. DESIGN AND METHODS: CON (n = 8; 50 ± 2 years; 31 ± 1 kg/m(2)) and MHD patients (n = 8; 56 ± 5 years; 32 ± 2 kg/m(2)) underwent a basal blood draw and muscle biopsy and serial blood draws after the ingestion of a mixed meal on a nondialysis day. Plasma advanced glycation end products (AGEs) and markers of oxidation were assessed via liquid chromatography–tandem mass spectrometry before and after the meal (+240 min). Circulating inflammatory cytokines and soluble receptors for AGE (sRAGE) isoforms (endogenous secretory RAGEs and cleaved RAGEs) were determined before and after the meal (+240 min). Basal muscle was probed for inflammatory cytokines and protein expression of related signaling components (RAGE, Toll-like receptor 4, oligosaccharyltransferase subunit 48, TIR-domain–containing adapter-inducing interferon-β, total IκBα, and pIκBα). RESULTS: Basal circulating AGEs were 7- to 343-fold higher (P < .001) in MHD than those in CON, but only MG-H1 increased in CON after the meal (P < .001). There was a group effect (MHD > CON) for total sRAGEs (P = .02) and endogenous secretory RAGEs (P < .001) and a trend for cleaved RAGEs (P=.09), with no meal effect. In addition, there was a group effect (MHD < CON; P < .05) for circulating fractalkine, interleukin (IL)10, IL17A, and IL1β and a trend (P < .10) for IL6 and macrophage inflammatory protein 1 alpha, whereas tumor necrosis factor alpha was higher in MHD (P < .001). In muscle, Toll-like receptor 4 (P = .03), TIR-domain–containing adapter-inducing interferon-β (P = .002), and oligosaccharyltransferase subunit 48 (P = .02) expression was lower in MHD than that in CON, whereas IL6 was higher (P = .01) and IL8 (P = .08) tended to be higher in MHD. CONCLUSION: Overall, MHD exhibited an exaggerated, circulating, and skeletal muscle inflammatory biomarker environment, and the meal did not appreciably affect the inflammatory status.
format Online
Article
Text
id pubmed-10580815
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-105808152023-10-17 Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal Perkins, Ryan K. van Vliet, Stephan Miranda, Edwin R. Fuller, Kelly N. Z. Beisswenger, Paul J. Wilund, Kenneth R. Paluska, Scott A. Burd, Nicholas A. Haus, Jacob M. J Ren Nutr Article OBJECTIVE: The goal of this investigation was to evaluate circulating and skeletal muscle inflammatory biomarkers between maintenance hemodialysis (MHD) and demographic-matched control subjects (CON) before and after ingestion of a protein-rich meal. DESIGN AND METHODS: CON (n = 8; 50 ± 2 years; 31 ± 1 kg/m(2)) and MHD patients (n = 8; 56 ± 5 years; 32 ± 2 kg/m(2)) underwent a basal blood draw and muscle biopsy and serial blood draws after the ingestion of a mixed meal on a nondialysis day. Plasma advanced glycation end products (AGEs) and markers of oxidation were assessed via liquid chromatography–tandem mass spectrometry before and after the meal (+240 min). Circulating inflammatory cytokines and soluble receptors for AGE (sRAGE) isoforms (endogenous secretory RAGEs and cleaved RAGEs) were determined before and after the meal (+240 min). Basal muscle was probed for inflammatory cytokines and protein expression of related signaling components (RAGE, Toll-like receptor 4, oligosaccharyltransferase subunit 48, TIR-domain–containing adapter-inducing interferon-β, total IκBα, and pIκBα). RESULTS: Basal circulating AGEs were 7- to 343-fold higher (P < .001) in MHD than those in CON, but only MG-H1 increased in CON after the meal (P < .001). There was a group effect (MHD > CON) for total sRAGEs (P = .02) and endogenous secretory RAGEs (P < .001) and a trend for cleaved RAGEs (P=.09), with no meal effect. In addition, there was a group effect (MHD < CON; P < .05) for circulating fractalkine, interleukin (IL)10, IL17A, and IL1β and a trend (P < .10) for IL6 and macrophage inflammatory protein 1 alpha, whereas tumor necrosis factor alpha was higher in MHD (P < .001). In muscle, Toll-like receptor 4 (P = .03), TIR-domain–containing adapter-inducing interferon-β (P = .002), and oligosaccharyltransferase subunit 48 (P = .02) expression was lower in MHD than that in CON, whereas IL6 was higher (P = .01) and IL8 (P = .08) tended to be higher in MHD. CONCLUSION: Overall, MHD exhibited an exaggerated, circulating, and skeletal muscle inflammatory biomarker environment, and the meal did not appreciably affect the inflammatory status. 2023-01 2021-12-17 /pmc/articles/PMC10580815/ /pubmed/34923111 http://dx.doi.org/10.1053/j.jrn.2021.11.006 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Perkins, Ryan K.
van Vliet, Stephan
Miranda, Edwin R.
Fuller, Kelly N. Z.
Beisswenger, Paul J.
Wilund, Kenneth R.
Paluska, Scott A.
Burd, Nicholas A.
Haus, Jacob M.
Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal
title Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal
title_full Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal
title_fullStr Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal
title_full_unstemmed Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal
title_short Advanced Glycation End Products and Inflammatory Cytokine Profiles in Maintenance Hemodialysis Patients After the Ingestion of a Protein-Dense Meal
title_sort advanced glycation end products and inflammatory cytokine profiles in maintenance hemodialysis patients after the ingestion of a protein-dense meal
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580815/
https://www.ncbi.nlm.nih.gov/pubmed/34923111
http://dx.doi.org/10.1053/j.jrn.2021.11.006
work_keys_str_mv AT perkinsryank advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT vanvlietstephan advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT mirandaedwinr advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT fullerkellynz advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT beisswengerpaulj advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT wilundkennethr advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT paluskascotta advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT burdnicholasa advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal
AT hausjacobm advancedglycationendproductsandinflammatorycytokineprofilesinmaintenancehemodialysispatientsaftertheingestionofaproteindensemeal